Qiang Huang Selected Research

Glioblastoma (Glioblastoma Multiforme)

5/2022	Bioinformatics analysis of potential glioblastoma circular RNA sponge network.
2/2021	Amlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway.
1/2021	CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway.
1/2021	LncRNA HAS2-AS1 Promotes Glioblastoma Proliferation by Sponging miR-137.
1/2020	ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.
8/2017	Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway.
7/2017	IKBKE promotes glioblastoma progression by establishing the regulatory feedback loop of IKBKE/YAP1/miR-Let-7b/i.
1/2017	Cathepsin L is involved in X-ray-induced invasion and migration of human glioma U251 cells.
1/2017	Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance.
1/2017	Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiang Huang Research Topics

Disease

143	Neoplasms (Cancer) 07/2022 - 02/2002
67	Glioma (Gliomas) 05/2022 - 05/2002
35	Infections 06/2022 - 06/2007
22	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 01/2003
21	Wounds and Injuries (Trauma) 04/2022 - 10/2003
18	Neoplasm Metastasis (Metastasis) 02/2022 - 09/2010
16	Inflammation (Inflammations) 01/2022 - 09/2004
15	Pain (Aches) 04/2022 - 05/2012
14	Cholangiocarcinoma 04/2019 - 04/2011
13	Carcinogenesis 01/2022 - 05/2006
12	Hemorrhage 01/2021 - 01/2011
11	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2010
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 09/2010
9	Squamous Cell Carcinoma of Head and Neck 01/2022 - 04/2014
9	Osteoporosis 01/2018 - 10/2008
8	Stroke (Strokes) 05/2022 - 01/2013
8	Postoperative Nausea and Vomiting (PONV) 04/2022 - 01/2018
7	Breast Neoplasms (Breast Cancer) 10/2022 - 08/2011
6	Body Weight (Weight, Body) 07/2022 - 03/2013
6	Hypoxia (Hypoxemia) 05/2022 - 12/2002
6	Stomach Neoplasms (Stomach Cancer) 05/2018 - 08/2013
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
5	Osteoarthritis 09/2021 - 05/2012
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2007
5	Adenocarcinoma 01/2020 - 01/2016
5	Liver Neoplasms (Liver Cancer) 01/2020 - 01/2015
5	Carcinoma (Carcinomatosis) 01/2020 - 02/2007
5	Pathologic Constriction (Stenosis) 01/2019 - 11/2012
5	Brain Neoplasms (Brain Tumor) 01/2017 - 06/2010
4	Surgical Wound Infection 01/2022 - 05/2018
4	Insulin Resistance 10/2019 - 01/2015
4	Venous Thromboembolism 10/2019 - 02/2017
4	Nausea 01/2019 - 11/2017
4	Tuberculosis (Tuberculoses) 06/2010 - 01/2007
3	Obesity 07/2022 - 10/2019
3	Ischemia 05/2022 - 06/2011
3	Mitochondrial Diseases (Mitochondrial Disease) 05/2022 - 10/2016

Drug/Important Bio-Agent (IBA)

49	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2004
24	Biomarkers (Surrogate Marker)IBA 06/2022 - 05/2011
23	Pharmaceutical PreparationsIBA 02/2022 - 10/2002
21	MicroRNAs (MicroRNA)IBA 05/2022 - 03/2012
20	Biological ProductsIBA 01/2021 - 08/2003
14	Interleukin-6 (Interleukin 6)IBA 04/2022 - 01/2012
12	Small Interfering RNA (siRNA)IBA 01/2021 - 09/2005
11	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022 - 01/2018
11	Messenger RNA (mRNA)IBA 01/2022 - 12/2004
11	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2010
11	Therapeutic UsesIBA 08/2020 - 10/2002
10	Circular RNAIBA 05/2022 - 09/2017
10	C-Reactive ProteinIBA 04/2022 - 01/2013
8	Blood Glucose (Blood Sugar)IBA 07/2022 - 11/2013
8	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 03/2007
8	Analgesics (Analgesic Drugs)IBA 04/2022 - 01/2018
8	Tranexamic Acid (AMCA)FDA Link 02/2022 - 01/2018
8	EnzymesIBA 01/2022 - 03/2006
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 03/2011
7	Hemoglobins (Hemoglobin)IBA 05/2022 - 02/2017
7	AntiemeticsIBA 04/2022 - 01/2018
6	RNA (Ribonucleic Acid)IBA 07/2022 - 03/2013
6	LipidsIBA 07/2022 - 10/2010
6	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 03/2007
6	Peptides (Polypeptides)IBA 01/2021 - 07/2004
6	SuspensionsIBA 02/2019 - 05/2006
6	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 06/2008
6	Red Fluorescent ProteinIBA 01/2016 - 12/2012
5	Polysaccharides (Glycans)IBA 07/2022 - 10/2016
5	fibrin fragment D (D-dimer)IBA 10/2021 - 01/2019
5	Sincalide FDA Link 01/2021 - 11/2013
5	CateninsIBA 01/2020 - 09/2015
5	Green Fluorescent ProteinsIBA 02/2019 - 08/2008
5	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2018 - 06/2007
5	GlucocorticoidsIBA 01/2018 - 07/2007
5	NestinIBA 02/2016 - 10/2008
5	Complementary DNA (cDNA)IBA 07/2007 - 05/2002
4	Coloring Agents (Dyes)IBA 10/2022 - 12/2004
4	Phosphotransferases (Kinase)IBA 01/2022 - 01/2014
4	Cadherins (E-Cadherin)IBA 04/2021 - 01/2012
4	LipopolysaccharidesIBA 01/2021 - 10/2015
4	Long Noncoding RNAIBA 01/2021 - 12/2018
4	Gemcitabine FDA Link 04/2019 - 10/2016
4	CytokinesIBA 01/2017 - 09/2014
4	Histones (Histone)IBA 01/2015 - 08/2012
4	Aurora Kinase BIBA 01/2015 - 08/2012
4	matrigelIBA 05/2011 - 06/2008
3	Fibrinogen (Factor I)FDA Link 06/2022 - 01/2020
3	AntioxidantsIBA 05/2022 - 03/2007

Therapy/Procedure

43	Therapeutics 04/2022 - 10/2002
15	Drug Therapy (Chemotherapy) 10/2020 - 01/2007
12	Knee Replacement Arthroplasty (Total Knee Replacement) 10/2021 - 02/2016
11	Length of Stay 10/2021 - 02/2017
8	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2022 - 10/2008
8	Radiotherapy 01/2018 - 01/2011
8	Transplantation 01/2016 - 03/2007
6	Stents 10/2019 - 10/2007
4	Arthroplasty 06/2022 - 01/2019
4	Debridement 10/2021 - 04/2012
4	Operative Time 09/2021 - 08/2013
4	Surgical Instruments (Clip) 02/2021 - 01/2006
4	Liver Transplantation 03/2014 - 01/2011
3	Oral Administration 07/2022 - 07/2017